Status:
UNKNOWN
Evaluation of the Antalgic Effect of Puressentiel Joints and Muscles - Gel on Joint Pain of the Knee
Lead Sponsor:
Marco Pacchioni
Conditions:
Pain
Joint Pain
Eligibility:
All Genders
45-90 years
Phase:
NA
Brief Summary
This clinical trial aims to evaluate the antalgic effect of Puressentiel Joints and Muscles - Gel with 14 essential oils for 12 weeks on knee joint pain in 45 patients suffering from chronic pain rela...
Detailed Description
This clinical trial aims to evaluate the antalgic effect of Puressentiel Joints and Muscles - Gel with 14 essential oils for 12 weeks on knee joint pain in 45 patients suffering from chronic pain rela...
Eligibility Criteria
Inclusion
- Subject smust be able to understand the terms of the written informed consent and must agree to date and sign it before any study procedure is carried out,
- Patient having signed the informed consent
- Aged 45 to 90
- With chronic osteoarthritis of the knee
- Patient with or without analgesic and anti-inflammatory treatment
Exclusion
- Patient at the stage of surgical osteoarthritis (grade 4 plus limitation of amplitude)
- Patient with a limited walking perimeter (\<100m) for any reason whatsoever
- Patient allergic to one of the components of the study product
- Patient not benefiting from social security
- Patient cannot be followed for the duration of the study
- Participation in another clinical trial within 30 days before V0
- Subjects who cannot understand or perform study procedures.
- Pregnant or breastfeeding women
- People with a history of convulsive or epileptic disorders
- People allergic to salicylates.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04736563
Start Date
February 1 2021
End Date
June 30 2021
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Foch
Suresnes, France, 9200